182 related articles for article (PubMed ID: 36527305)
1. Current status and novel insights into the role of metastasectomy in the era of immunotherapy.
Liatsou E; Tsilimigras DI; Malandrakis P; Gavriatopoulou M; Ntanasis-Stathopoulos I
Expert Rev Anticancer Ther; 2023 Jan; 23(1):57-66. PubMed ID: 36527305
[TBL] [Abstract][Full Text] [Related]
2. Surgical metastasectomy for metastatic renal cell carcinoma in the era of targeted and immune therapy: a narrative review.
Tayeh GA; Alkassis M; De La Taille A; Vordos D; Champy CM; Pelegrin T; Ingels A
World J Urol; 2024 Jan; 42(1):51. PubMed ID: 38244094
[TBL] [Abstract][Full Text] [Related]
3. The role of metastasectomy in advanced renal cell carcinoma.
Apollonio G; Raimondi A; Verzoni E; Claps M; Sepe P; Pagani F; Ratta R; Montorsi F; De Braud FGM; Procopio G
Expert Rev Anticancer Ther; 2019 Jul; 19(7):603-611. PubMed ID: 31159619
[No Abstract] [Full Text] [Related]
4. Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.
Kim DY; Karam JA; Wood CG
World J Urol; 2014 Jun; 32(3):631-42. PubMed ID: 24744223
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy in renal cell carcinoma in the immunotherapy era: where do we stand?
Zouein J; Naim N; Kourie HR
Immunotherapy; 2023 Feb; 15(2):93-100. PubMed ID: 36601860
[TBL] [Abstract][Full Text] [Related]
6. Surgical outcomes of pulmonary metastasectomy for head and neck cancer in the current era of advances in chemotherapy and immunotherapy.
Ochi T; Wada H; Nakajima T; Tanaka K; Yamamoto T; Sakairi Y; Suzuki H; Yonekura S; Hanazawa T; Yoshino I
Gen Thorac Cardiovasc Surg; 2021 Aug; 69(8):1214-1221. PubMed ID: 33754238
[TBL] [Abstract][Full Text] [Related]
7. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
[TBL] [Abstract][Full Text] [Related]
8. The Evolving Role of Metastasectomy for Patients with Metastatic Renal Cell Carcinoma.
Dr Hall B; Abel EJ
Urol Clin North Am; 2020 Aug; 47(3):379-388. PubMed ID: 32600539
[TBL] [Abstract][Full Text] [Related]
9. The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma.
Dibajnia P; Cardenas LM; Lalani AA
Hum Vaccin Immunother; 2023 Dec; 19(1):2178217. PubMed ID: 36775257
[TBL] [Abstract][Full Text] [Related]
10. The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
Ljungberg B
Curr Urol Rep; 2013 Feb; 14(1):19-25. PubMed ID: 23212738
[TBL] [Abstract][Full Text] [Related]
11. Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.
Karam JA; Rini BI; Varella L; Garcia JA; Dreicer R; Choueiri TK; Jonasch E; Matin SF; Campbell SC; Wood CG; Tannir NM
J Urol; 2011 Feb; 185(2):439-44. PubMed ID: 21167518
[TBL] [Abstract][Full Text] [Related]
12. Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions.
Donini M; Buti S; Massari F; Mollica V; Rizzo A; Montironi R; Bersanelli M; Santoni M
Expert Rev Anticancer Ther; 2020 Jun; 20(6):491-501. PubMed ID: 32479120
[TBL] [Abstract][Full Text] [Related]
13. Role of metastasectomy in metastatic renal cell carcinoma.
Thomas AZ; Adibi M; Borregales LD; Wood CG; Karam JA
Curr Opin Urol; 2015 Sep; 25(5):381-9. PubMed ID: 26125508
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapy following metastasectomy for renal cell carcinoma: Using insights from other clinical settings to address unanswered questions.
Appleman LJ; Maranchie JK
Urol Oncol; 2018 Jan; 36(1):17-22. PubMed ID: 28736252
[TBL] [Abstract][Full Text] [Related]
15. Metastasectomy in patients with renal cell carcinoma: when and how?
Omid S; Abufaraj M; Remzi M
Curr Opin Urol; 2020 Jul; 30(4):602-609. PubMed ID: 32464043
[TBL] [Abstract][Full Text] [Related]
16. [The Treatment of Metastatic Renal Cell Carcinoma: An Update].
Pezzicoli G; Ganini C; Re Sartò GV; Pirovano M; Cosmai L; Porta C
G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007832
[TBL] [Abstract][Full Text] [Related]
17. Treatment strategies for advanced renal cell carcinoma: A new paradigm for surgical treatment.
Tomita Y
Int J Urol; 2016 Jan; 23(1):13-21. PubMed ID: 26347163
[TBL] [Abstract][Full Text] [Related]
18. Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
Wong P; Wisneski AD; Tsai KK; Chang TT; Hirose K; Nakakura EK; Daud AI; Maker AV; Corvera CU
World J Surg Oncol; 2024 Mar; 22(1):77. PubMed ID: 38468341
[TBL] [Abstract][Full Text] [Related]
19. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy for advanced renal cell carcinoma.
Meissner MA; McCormick BZ; Karam JA; Wood CG
Expert Rev Anticancer Ther; 2018 Jul; 18(7):663-671. PubMed ID: 29707987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
